Written question asked by Tony Lloyd (Labour) on Tuesday, 12 January 2021, in the House of Commons. It was due for an answer on Tuesday, 19 January 2021 (named day). A holding answer was provided on Tuesday, 19 January 2021. A substantive answer was provided by Jo Churchill (Conservative) on Friday, 12 February 2021 on behalf of the Department of Health and Social Care.
Cannabis: Medical Treatments
- Question
-
To ask the Secretary of State for Health and Social Care, what his policy is on access to medical cannabis following disruption of supplies after the end of the transition period.
- Answer
-
The Department, supported by the British Embassy to The Hague, has reached an agreement with the Dutch Government to allow the continued supply of Bedrocan oils, a form of unlicensed medicinal cannabis, against United Kingdom prescriptions for existing patients until 1 July 2021. The medicines supply chain has ensured that there continues to be good supply of licensed and unlicensed cannabis-based medicines after the transition period.
The Written Ministerial Statement of 26 January (HCWS734) provided an update on action taken by the Government on supply from the Netherlands and next steps to establish a more permanent solution.
Secondary information
- Type
- Written question
- Reference
- 136452
- Session
- 2019-21
- Related items
-
Update on supply of Medicinal Cannabis from The Netherlands
Tuesday, 26 January 2021
Written statements
House of Commons
- Subjects
- Cannabis Medical treatments Brexit
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2024-07-26 12:17:35 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/136452
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/136452
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/136452